JPRN-UMIN000015566
Completed
Phase 1
Phase I study of neo-adjuvant chemoradiation therapy for newly diagnosed malignant astrocytomas - neoadjuvant chemoradiation for malignant astrocytomas
Chiba Cancer Center0 sites20 target enrollmentNovember 1, 2014
Conditionsmalignant astyrocytomas
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- malignant astyrocytomas
- Sponsor
- Chiba Cancer Center
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •large tumor (\>6cm) sign of tent\-herniation existence of extracranial malignant tumor pregnancy psychological disorder HIV positive patients history of pneumonitis history of radiation therapy for intracranial lesions
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A phase I/II study of neoadjuvant chemoradiotherapy for pancreatic cancer.JPRN-UMIN000042932The Jikei University school of medicine58
Completed
Not Applicable
Phase II study of neoadjuvant chemoradiotherapy of s-1 and cisplatin for advanced gastric cancer with lymph node metastases (Neo-KOGC04 study)Advanced Gastric CancerJPRN-UMIN000014331School of Medicine, Keio University30
Not yet recruiting
Not Applicable
eoadjuvant chemoradiotherapy with protons for resectable esophageal cancerKCT0005576ational Cancer Center68
Recruiting
Phase 1
Phase I, II study of neoadjuvant chemotherapy with gemcitabine and nab-paclitaxel for resectable pancreatic cancerpancreatic ductal cancerJPRN-jRCTs021200003Ishido Keinosuke30
Active, not recruiting
Not Applicable
PHASE II STUDY OF NEOADJUVANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED RECTAL CANCER - XELOXARTrectal cancerMedDRA version: 6.1Level: PTClassification code 10062099EUCTR2005-005661-11-ITAZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO